Iowa lawmakers are tackling a $20 billion blind spot in pharmaceutical regulation—and the implications reach far beyond state borders.
A Compliance Revolution Brewing in the Heartland
When most people think about pharmaceutical regulation, they picture traditional pharmacies with their familiar orange prescription bottles and white-coated pharmacists. But there’s a massive segment of the healthcare industry dispensing prescription medications with virtually no oversight: medical spas and wellness clinics.
Iowa is about to change that equation dramatically.
